JTCVS Techniques (Dec 2023)

Assessment of effectiveness and safety of thrombolytic therapy to pulmonary emboli by endobronchial ultrasound-guided transbronchial needle injectionCentral MessagePerspective

  • Yuki Sata, MD, PhD,
  • Masato Aragaki, MD, PhD,
  • Terunaga Inage, MD, PhD,
  • Nicholas Bernards, PhD,
  • Alexander Gregor, MD, PhD,
  • Shinsuke Kitazawa, MD, PhD,
  • Fumi Yokote, MD, PhD,
  • Takamasa Koga, MD, PhD,
  • Hiroyuki Ogawa, MD, PhD,
  • Yoshihisa Hiraishi, MD, PhD,
  • Tsukasa Ishiwata, MD, PhD,
  • Andrew Effat, MS,
  • Kate Kazlovich, MS,
  • Harley Chan, PhD,
  • Ichiro Yoshino, MD, PhD,
  • Kazuhiro Yasufuku, MD, PhD, FRCSC

DOI
https://doi.org/10.1016/j.xjtc.2023.09.005
Journal volume & issue
Vol. 22
pp. 292 – 304

Abstract

Read online

Objective: Endobronchial ultrasound–guided transbronchial needle injection (EBUS-TBNI) may effectively treat acute pulmonary embolisms (PEs). Here, we assessed the effectiveness of clot dissolution and safety of tissue plasminogen activator (t-PA) injection using EBUS-TBNI in a 1-week survival study of a porcine PE model. Methods: Six pigs with bilateral PEs were used: 3 for t-PA injection using EBUS-TBNI (TBNI group) and 3 for systemic administration of t-PA (systemic group). Once bilateral PEs were created, each 25 mg of t-PA injection using EBUS-TBNI for bilateral PEs (a total of 50 mg t-PA) and 100 mg of t-PA systemic administration was performed on day 1. Hemodynamic parameters, blood tests, and contrast-enhanced computed tomography scans were carried out at several time points. On day 7, pigs were humanely killed to evaluate the residual clot volume in the pulmonary arteries. Results: The average of percent change of residual clot volumes was significantly lower in the TBNI group than in the systemic group (%: systemic group 36.6 ± 22.6 vs TBNI group 9.6 ± 6.1, P < .01) on day 3. Considering the elapsed time, the average decrease of clot volume per hour at pre-t-PA to post t-PA was significantly greater in the TBNI group than in the systemic group (mm3/hour: systemic 68.1 ± 68.1 vs TBNI 256.8 ± 148.1, P < .05). No hemorrhage was observed intracranially, intrathoracically, or intraperitoneally on any contrast-enhanced computed tomography images. Conclusions: This study revealed that t-PA injection using EBUS-TBNI is an effective and safe way to dissolve clots.

Keywords